Hyman Bernard Muss

UNCCH, School of Medicine, Medicine

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network

Hyman Bernard Muss

• Organizations
  University of North Carolina at Chapel Hill
  
  School of Medicine
  
  Medicine
  
  

Help us refine your profile

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  James L. Khatcheressian; Patricia Hurley; Elissa Bantug; Laura J. Esserman; Eva Grunfeld; Francine Halberg; Alexander Hantel; N. Lynn Henry; Hyman B. Muss; Thomas J. Smith; et al.

  Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update

  Journal of Clinical Oncology. 2013;31(7):961-965.
  0

• 2.

  2013

  P.E. Goss; J.N. Ingle; S. Martino; N.J. Robert; H.B. Muss; R.B. Livingston; N.E. Davidson; E.A. Perez; Y. Chavarri-Guerra; D.A. Cameron; et al.

  Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

  Annals of Oncology. 2013;24(2):355-361.
  0

• 3.

  2012

  K.J. Ruddy; B.N. Pitcher; L.E. Archer; H.J. Cohen; E.P. Winer; C.A. Hudis; H.B. Muss; A.H. Partridge

  Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence companion study 60104 for CALGB 49907)

  Annals of Oncology. 2012;23(12):3075-3081.
  0

• 4.

  2012

  Lawrence N. Shulman; Constance T. Cirrincione; Donald A. Berry; Heather P. Becker; Edith A. Perez; Ruth O'Regan; Silvana Martino; James N. Atkins; Erica Mayer; Charles J. Schneider; et al.

  Six cycles of doxorubicin and cyclophosphamide or paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and leukemia group B 40101

  Journal of Clinical Oncology. 2012;30(33):4071-4076.
  3

• 5.

  2012

  Susan R. Sturgeon; Raji Balasubramanian; Catherine Schairer; Hyman B. Muss; Regina G. Ziegler; Kathleen F. Arcaro

  Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls

  Epigenetics. 2012;7(11):1258-1267.
  0

• 6.

  2012

  Clifford A. Hudis; Marc L. Citron; Hy Muss; Larry Norton; Eric P. Winer

  Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?

  Journal of Clinical Oncology. 2012;30(25):3148-3149.
  2

• 7.

  2012

  Ellen L Jones; Ashley Leak; Hyman B Muss

  Adjuvant therapy of breast cancer in women 70 years of age and older: tough decisions, high stakes.

  Oncology (Williston Park, N.Y.). 2012;26(9):793-801.
  0

• 8.

  2012

  Hyman B. Muss; Debra L. Bynum

  Adjuvant chemotherapy in older patients with stage III colon cancer: An underused lifesaving treatment

  Journal of Clinical Oncology. 2012;30(21):2576-2578.
  3

• 9.

  2012

  Lee W. Jones; Kerry S. Courneya; John R. Mackey; Hyman B. Muss; Edith N. Pituskin; Jessica M. Scott; Whitney E. Hornsby; April D. Coan; James E. Herndon II; Pamela S. Douglas; et al.

  Cardiopulmonary function and age-related decline across the breast cancer: Survivorship continuum

  Journal of Clinical Oncology. 2012;30(20):2530-2537.
  6

• 10.

  2012

  Trevor Jolly; Grant R. Williams; Ellen Jones; Hyman B. Muss

  Treatment of metastatic breast cancer in women aged 65 years and older

  Women's Health. 2012;8(4):455-471.
  0

• 11.

  2012

  William Dale; Supriya G. Mohile; Basil A. Eldadah; Edward L. Trimble; Richard L. Schilsky; Harvey J. Cohen; Hyman B. Muss; Kenneth E. Schmader; Betty Ferrell; Martine Extermann; et al.

  Biological, clinical, and psychosocial correlates at the interface of cancer and aging research

  Journal of the National Cancer Institute. 2012;104(8):581-589.
  5

• 12.

  2012

  S.M. Lichtman; A. Hurria; C.T. Cirrincione; A.D. Seidman; E. Winer; C. Hudis; H.J. Cohen; H.B. Muss

  Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: Combined analysis of calgb 9342 and 9840

  Annals of Oncology. 2012;23(3):632-638.
  2

• 13.

  2012

  Ellen L. Jones; Ashley Leak; Hyman B. Muss

  Adjuvant therapy of breast cancer in women 70 years of age and older: Tough decisions, high stakes

  ONCOLOGY (United States). 2012;26(9).
  0

• 14.

  2011

  Hyman B. Muss; Jan Busby-Whitehead

  Older women with breast cancer: Slow progress, great opportunity, now is the time

  Journal of Clinical Oncology. 2011;29(35):4608-4610.
  4

• 15.

  2011

  Natalie Sinclair; Benjamin Littenberg; Berta Geller; Hyman Muss

  Accuracy of screening mammography in older women

  American Journal of Roentgenology. 2011;197(5):1268-1273.
  6

• 16.

  2011

  William Irvin Jr.; Hyman B. Muss; Deborah K. Mayer

  Symptom management in metastatic breast cancer

  Oncologist. 2011;16(9):1203-1214.
  2

• 17.

  2011

  A. Ring; M. Reed; R. Leonard; I. Kunkler; H. Muss; H. Wildiers; L. Fallowfield; A. Jones; R. Coleman

  The treatment of early breast cancer in women over the age of 70

  British Journal of Cancer. 2011;105(2):189-193.
  8

• 18.

  2011

  Arti Hurria; Constance T. Cirrincione; Hyman B. Muss; Alice B. Kornblith; William Barry; Andrew S. Artz; Linda Schmieder; Rafat Ansari; William P. Tew; Douglas Weckstein; et al.

  Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401

  Journal of Clinical Oncology. 2011;29(10):1290-1296.
  31

• 19.

  2011

  Alice B. Kornblith; Lan Lan; Laura Archer; Ann Partridge; Gretchen Kimmick; Clifford Hudis; Eric Winer; Rebecca Casey; Samantha Bennett; Harvey Jay Cohen; et al.

  Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: A companion study to cancer and leukemia group B 49907

  Journal of Clinical Oncology. 2011;29(8):1022-1028.
  9

• 20.

  2011

  Nehmat Houssami; Linn A. Abraham; Diana L. Miglioretti; Edward A. Sickles; Karla Kerlikowske; Diana S. M. Buist; Berta M. Geller; Hyman B. Muss; Les Irwig

  Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer

  JAMA - Journal of the American Medical Association. 2011;305(8):790-799.
  19

• 21.

  2011

  Hyman B. Muss

  From medical oncologist to geriatric oncologist-Worth the trip

  Journal of Geriatric Oncology. 2011;2(1):82-84.
  0

• 22.

  2011

  Witherby Sabrina; Julia Johnson; Laurence Demers; Sharon Mount; Benjamin Littenberg; Charles D. Maclean; Marie Wood; Hyman Muss

  Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: A phase I/II study

  Oncologist. 2011;16(4):424-431.
  8

• 23.

  2011

  Hyman B Muss

  Coming of age: breast cancer in seniors.

  The oncologist. 2011;16 Suppl 1:79-87.
  4

• 24.

  2010

  Marie Wood; Teresa Fama; Takamaru Ashikaga; Hyman Muss

  Discrepancy between preference and actual adjuvant therapy for breast cancer

  Clinical Breast Cancer. 2010;10(5):398-403.
  0

• 25.

  2010

  Hyman B. Muss; Helen Anne D'Alessandro; Elena F. Brachtel

  The authors reply

  New England Journal of Medicine. 2010;363(13):1288.
  0

• 26.

  2010

  Jeanne S. Mandelblatt; Vanessa B. Sheppard; Arti Hurria; Gretchen Kimmick; Claudine Isaacs; Kathryn L. Taylor; Alice B. Kornblith; Anne-Michelle Noone; Gheorghe Luta; Michelle Tallarico; et al.

  Breast cancer adjuvant chemotherapy decisions in older women: The role of patient preference and interactions with physicians

  Journal of Clinical Oncology. 2010;28(19):3146-3153.
  11

• 27.

  2010

  William A Wood; Hyman Muss

  Quantitation of individual risk for osteoporotic fracture.

  Oncology (Williston Park, N.Y.). 2010;24(8):753-755.
  0

• 28.

  2010

  W. Chris Taylor; Hyman B. Muss

  Adjuvant therapy for older women with breast cancer

  Cancer Journal. 2010;16(4):289-293.
  4

• 29.

  2010

  William A. Wood; Hyman Muss

  Quantitation of individual risk for osteoporotic fracture

  ONCOLOGY. 2010;24(8).
  0

• 30.

  2010

  W. Chris Taylor; Hyman B. Muss

  Adjuvant chemotherapy of breast cancer in the older patient

  ONCOLOGY. 2010;24(7).
  0

• 31.

  2010

  W Chris Taylor; Hyman B Muss

  Adjuvant chemotherapy of breast cancer in the older patient.

  Oncology (Williston Park, N.Y.). 2010;24(7):608-613.
  1

• 32.

  2010

  Hyman B. Muss; Helen Anne D'Alessandro; Elena F. Brachtel

  Case 15-2010: An 85-year-old woman with mammographically detected early breast cancer

  New England Journal of Medicine. 2010;362(20):1921-1928+1862.
  2

• 33.

  2010

  Ann H. Partridge; Laura Archer; Alice B. Kornblith; Julie Gralow; Debjani Grenier; Edith Perez; Antonio C. Wolff; Xiaofei Wang; Helen Kastrissios; Donald Berry; et al.

  Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: Adherence companion study 60104

  Journal of Clinical Oncology. 2010;28(14):2418-2422.
  15

• 34.

  2010

  Laura C. Hanson; Hyman B. Muss

  Cancer in the oldest old: Making better treatment decisions

  Journal of Clinical Oncology. 2010;28(12):1975-1976.
  4

• 35.

  2010

  Hyman B Muss

  Coming of age: breast cancer in seniors.

  The oncologist. 2010;15 Suppl 5:57-65.
  3

• 36.

  2009

  Hyman B. Muss; Donald A. Berry; Constance T. Cirrincione

  The authors reply

  New England Journal of Medicine. 2009;361(10):1023-1024.
  0

• 37.

  2009

  Hyman B. Muss; Donald A. Berry; Constance T. Cirrincione; Maria Theodoulou; Ann M. Mauer; Alice B. Kornblith; Ann H. Partridge; Lynn G. Dressler; Harvey J. Cohen; Heather P. Becker; et al.

  Adjuvant chemotherapy in older women with early-stage breast cancer

  New England Journal of Medicine. 2009;360(20):2055-2065.
  140

• 38.

  2009

  Steven M. Grunberg; Matthew Dugan; Hyman Muss; Marie Wood; Susan Burdette-Radoux; Tracey Weisberg; Marisa Siebel

  Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy

  Supportive Care in Cancer. 2009;17(5):589-594.
  37

• 39.

  2009

  Stephen Jones; Frankie Ann Holmes; Joyce O'Shaughnessy; Joanne L. Blum; Svetislava J. Vukelja; Kristi J. Mclntyre; John E. Pippen; James H. Bordelon; Robert L. Kirby; John Sandbach; et al.

  Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of us oncology research trial 9735

  Journal of Clinical Oncology. 2009;27(8):1177-1183.
  148

• 40.

  2009

  Theresa Casey; Jeffrey Bond; Scott Tighe; Timothy Hunter; Laura Lintault; Osman Patel; Jonathan Eneman; Abigail Crocker; Jeffrey White; Joseph Tessitore; et al.

  Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer

  Breast Cancer Research and Treatment. 2009;114(1):47-62.
  39

• 41.

  2009

  H.B. Muss

  Cancer in the Elderly: a Societal Perspective from the United States

  Clinical Oncology. 2009;21(2):92-98.
  10

• 42.

  2009

  Susan Burdette-Radoux; Hyman B. Muss

  A question of duration: Do patients with early-stage breast cancer need more than five years of Adjuvant endocrine therapy?

  Clinical Breast Cancer. 2009;9(SUPPL.1):S37-S41.
  4

• 43.

  2009

  Kathy S Albain; William E Barlow; Peter M Ravdin; William B Farrar; Gary V Burton; Steven J Ketchel; Charles D Cobau; Ellis G Levine; James N Ingle; Kathleen I Pritchard; et al.

  Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

  The Lancet. 2009;374(9707):2055-2063.
  64

• 44.

  2008

  Paul Goss; Hyman Muss; James Ingle; Timothy Whelan; Melinda Wu

  Extended adjuvant endocrine therapy in breast cancer: Current status and future directions

  Clinical Breast Cancer. 2008;8(5):411-417.
  15

• 45.

  2008

  Theresa M. Casey; Jonathan Eneman; Abigail Crocker; Jeffrey White; Joseph Tessitore; Mary Stanley; Seth Harlow; Janice Y. Bunn; Donald Weaver; Hyman Muss; et al.

  Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: A population study

  Breast Cancer Research and Treatment. 2008;110(1):39-49.
  29

• 46.

  2008

  Chris E. Holmes; Joe C. Huang; Thomas R. Pace; Alan B. Howard; Hyman B. Muss

  Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer

  Clinical Cancer Research. 2008;14(10):3070-3076.
  6

• 47.

  2008

  James N. Ingle; D. Tu; J.L. Pater; H.B. Muss; S. Martino; N.J. Robert; M.J. Piccart; M. Castiglione; L.E. Shepherd; K.I. Pritchard; et al.

  Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17

  Annals of Oncology. 2008;19(5):877-882.
  27

• 48.

  2008

  Judith-Anne W. Chapman; Daniel Meng; Lois Shepherd; Wendy Parulekar; James N. Ingle; Hyman B. Muss; Michael Palmer; Changhong Yu; Paul E. Goss

  Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer

  Journal of the National Cancer Institute. 2008;100(4):252-260.
  43

• 49.

  2008

  Hyman B. Muss; Dongsheng Tu; James N. Ingle; Silvana Martino; Nicholas J. Robert; Joseph L. Pater; Timothy J. Whelan; Michael J. Palmer; Martine J. Piccart; Lois E. Shepherd; et al.

  Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17

  Journal of Clinical Oncology. 2008;26(12):1956-1964.
  40

• 50.

  2008

  Paul E. Goss; James N. Ingle; Joseph L. Pater; Silvana Martino; Nicholas J. Robert; Hyman B. Muss; Martine J. Piccart; Monica Castiglione; Lois E. Shepherd; Kathleen I. Pritchard; et al.

  Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen

  Journal of Clinical Oncology. 2008;26(12):1948-1955.
  76

• 51.

  2008

  Andrew D. Seidman; Donald Berry; Constance Cirrincione; Lyndsay Harris; Hyman Muss; P. Kelly Marcom; Grandella Gipson; Harold Burstein; Diana Lake; Charles L. Shapiro; et al.

  Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: Final results of cancer and leukemia group B protocol 9840

  Journal of Clinical Oncology. 2008;26(10):1642-1649.
  218

• 52.

  2008

  Michael P. DiGiovanna; David F. Stern; Susan Edgerton; Gloria Broadwater; Lynn G. Dressler; Daniel R. Budman; I. Craig Henderson; Larry Norton; Edison T. Liu; Hyman B. Muss; et al.

  Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: Study 8541 from the cancer and leukemia group B

  Journal of Clinical Oncology. 2008;26(14):2364-2372.
  5

• 53.

  2008

  Blase N. Polite; Constance Cirrincione; Gini F. Fleming; Donald A. Berry; Andrew Seidman; Hyman Muss; Larry Norton; Charles Shapiro; Kamal Bakri; Kelly Marcom; et al.

  Racial differences in clinical outcomes from metastatic breast cancer: A pooled analysis of CALGB 9342 and 9840 - Cancer and leukemia group B

  Journal of Clinical Oncology. 2008;26(16):2659-2665.
  16

• 54.

  2008

  Hyman B. Muss

  Adjuvant chemotherapy for older women with breast cancer

  Breast Cancer Online. 2008;11(11).
  0

• 55.

  2007

  Kim Dittus; Hyman B. Muss

  Management of the frail elderly with breast cancer

  ONCOLOGY. 2007;21(14):1727-1734.
  9

• 56.

  2007

  Hans Wildiers; Ian Kunkler; Laura Biganzoli; Jacques Fracheboud; George Vlastos; Chantal Bernard-Marty; Arti Hurria; Martine Extermann; Véronique Girre; et al.

  Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

  Lancet Oncology. 2007;8(12):1101-1115.
  135

• 57.

  2007

  Hyman B. Muss; Donald A. Berry; Constance Cirrincione; Daniel R. Budman; I. Craig Henderson; Marc L. Citron; Larry Norton; Eric P. Winer; Clifford A. Hudis

  Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B experience

  Journal of Clinical Oncology. 2007;25(24):3699-3704.
  75

• 58.

  2007

  Hyman B. Muss; Janice Yanushka Bunn; Abigail Crocker; Karen Plaut; James Koh; Nick Heintz; Mercedes Rincon; Donald L. Weaver; Diane Tam; Barbara Beatty; et al.

  Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen

  Breast Journal. 2007;13(4):337-345.
  5

• 59.

  2007

  Paul E. Goss; James N. Ingle; Silvana Martino; Nicholas J. Robert; Hyman B. Muss; Martine J. Piccart; Monica Castiglione; Dongsheng Tu; Lois E. Shepherd; Kathleen I. Pritchard; et al.

  Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17

  Journal of Clinical Oncology. 2007;25(15):2006-2011.
  60

• 60.

  2007

  Hyman B. Muss; Laura Biganzoli; Daniel J. Sargent; Matti Aapro

  Adjuvant therapy in the elderly: Making the right decision

  Journal of Clinical Oncology. 2007;25(14):1870-1875.
  45

• 61.

  2007

  Diana Crivellari; Matti Aapro; Robert Leonard; Gunter Von Minckwitz; Etienne Brain; Aron Goldhirsch; Andrea Veronesi; Hyman Muss

  Breast cancer in the elderly

  Journal of Clinical Oncology. 2007;25(14):1882-1890.
  80

• 62.

  2007

  Susan Burdette-Radoux; Marie E. Wood; Julie J. Olin; Rebecca S. Laughlin; Abigail M. Crocker; Takamaru Ashikaga; Hyman B. Muss

  Phase I/II trial of adjuvant dose-dense docetaxel/epirubicin/ cyclophosphamide (TEC) in stage II and III breast cancer

  Breast Journal. 2007;13(3):274-280.
  7

• 63.

  2007

  H.B. Muss

  Adjuvant treatment of elderly breast cancer patients

  Breast. 2007;16(2 SUPPL.):159-165.
  10

• 64.

  2006

  Hyman B. Muss

  Targeted therapy for metastatic breast cancer

  New England Journal of Medicine. 2006;355(26):2783-2785.
  11

• 65.

  2006

  Mercedes Rincon; Gloria Broadwater; Lyndsay Harris; Abigail Crocker; Donald Weaver; Lynn Dressler; Donald Berry; Linda Sutton; Richard Michaelson; Michael Messino; et al.

  Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: Results of cancer and leukemia group B trial 159806

  Breast Cancer Research and Treatment. 2006;100(3):301-308.
  9

• 66.

  2006

  James L. Khatcheressian; Antonio C. Wolff; Thomas J. Smith; Eva Grunfeld; Hyman B. Muss; Victor G. Vogel; Francine Halberg; Mark R. Somerfield; Nancy E. Davidson

  American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

  Journal of Clinical Oncology. 2006;24(31):5091-5097.
  245

• 67.

  2006

  James N. Ingle; Dongsheng Tu; Joseph L. Pater; Silvana Martino; Nicholas J. Robert; Hyman B. Muss; Martine J. Piccart; Monica Castiglione; Lois E. Shepherd; Kathleen I. Pritchard; et al.

  Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

  Breast Cancer Research and Treatment. 2006;99(3):295-300.
  62

• 68.

  2006

  Arti Hurria; Mark S. Lachs; Harvery J. Cohen; Hyman B. Muss; Alice B. Kornblith

  Geriatric assessment for oncologists: Rationale and future directions

  Critical Reviews in Oncology/Hematology. 2006;59(3):211-217.
  48

• 69.

  2006

  Harvey Jay Cohen; Hyman B. Muss

  The Cancer and Leukemia Group B Cancer in the Elderly Committee: Addressing a major cancer need

  Clinical Cancer Research. 2006;12(11 II):3606s-3611s.
  10

• 70.

  2006

  Harold J. Burstein; Erica Mayer; Ann H. Partridge; Holly O'Kane; Georgia Litsas; Steven E. Come; Clifford A. Hudis; Donald F. Goldstein; Hyman B. Muss; et al.

  Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: Cases and lessons

  Clinical Breast Cancer. 2006;7(2):158-161.
  12

• 71.

  2006

  Donald A. Berry; Constance Cirrincione; I. Craig Henderson; Marc L. Citron; Daniel R. Budman; Lori J. Goldstein; Silvana Martino; Edith A. Perez; Hyman B. Muss; Larry Norton; et al.

  Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

  Journal of the American Medical Association. 2006;295(14):1658-1667.
  339

• 72.

  2006

  J. Herrstedt; H.B. Muss; D.G. Warr

  Erratum: Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy (Cancer (2005) 104 (1548-1555))

  Cancer. 2006;106(7):1641.
  1

• 73.

  2006

  Susan Burdette-Radoux; Hyman B. Muss

  Adjuvant chemotherapy in the elderly: Whom to treat, what regimen?

  Oncologist. 2006;11(3):234-242.
  15

• 74.

  2006

  Gretchen G. Kimmick; James Lovato; Richard McQuellon; Emily Robinson; Hyman B. Muss

  Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

  Breast Journal. 2006;12(2):114-122.
  72

• 75.

  2006

  Marcus E. Randall; Virginia L. Filiaci; Hyman Muss; Nick M. Spirtos; Robert S. Mannel; Jeffrey Fowler; J. Tate Thigpen; Jo Ann Benda; Denise Mackey

  Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study

  Journal of Clinical Oncology. 2006;24(1):36-44.
  277

• 76.

  2006

  Hyman B. Muss

  The future

  ONCOLOGY. 2006;20(2):146+151-152.
  0

• 77.

  2006

  Sabrina M. Witherby; Hyman B. Muss

  Managing early-stage breast cancer in your older patients

  ONCOLOGY. 2006;20(9):1003-1012.
  5

• 78.

  2005

  O. Abe; R. Abe; K. Enomoto; K. Kikuchi; H. Koyama; H. Masuda; Y. Nomura; K. Sakai; K. Sugimachi; T. Tominaga; et al.

  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

  Lancet. 2005;366(9503):2087-2106.
  1675

• 79.

  2005

  S.M. Witherby; Hyman B. Muss

  Special issues related to breast cancer adjuvant therapy in older women

  Breast. 2005;14(6):600-611.
  13

• 80.

  2005

  Edith Perez; Hyman B Muss

  Optimizing adjuvant chemotherapy in early-stage breast cancer.

  Oncology (Williston Park, N.Y.). 2005;19(14):1759-1767; discussion 1768, 1772-1774, 1777-1778.
  9

• 81.

  2005

  S.M. Witherby; Hyman B. Muss

  Update in medical oncology for older patients: Focus on breast cancer: Management of early breast cancer

  Cancer Journal. 2005;11(6):506-517.
  7

• 82.

  2005

  Arti Hurria; Supriya Gupta; Marjorie Zauderer; Enid L. Zuckerman; Harvey J. Cohen; Hyman Muss; Miriam Rodin; Katherine S. Panageas; Jimmie C. Holland; Leonard Saltz; et al.

  Developing a cancer-specific geriatric assessment: A feasibility study

  Cancer. 2005;104(9):1998-2005.
  135

• 83.

  2005

  Jørn Herrstedt; Hyman B. Muss; David G. Warr; Paul J. Hesketh; Peter D. Eisenberg; Harry Raftopoulos; Steven M. Grunberg; Munir Gabriel; Anthony Rodgers; et al.

  Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy

  Cancer. 2005;104(7):1548-1555.
  54

• 84.

  2005

  Susan Burdette-Radoux; Hyman B. Muss

  The Winell/Roth article reviewed

  ONCOLOGY. 2005;19(11):1504-1507.
  0

• 85.

  2005

  Paul E. Goss; James N. Ingle; Silvana Martino; Nicholas J. Robert; Hyman B. Muss; Martine J. Piccart; Monica Castiglione; Dongsheng Tu; Lois E. Shepherd; Kathleen I. Pritchard; et al.

  Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17

  Journal of the National Cancer Institute. 2005;97(17):1262-1271.
  615

• 86.

  2005

  Elizabeth B. Lamont; James E. Herndon II; Jane C. Weeks; I. Craig Henderson; Rogerio Lilenbaum; Richard L. Schilsky; Nicholas A. Christakis; Lee S. Schwartzberg; Stephen George; Stephen Grubbs; et al.

  Criterion validity of medicare chemotherapy claims in cancer and leukemia group B breast and lung cancer trial participants

  Journal of the National Cancer Institute. 2005;97(14):1080-1083.
  34

• 87.

  2005

  Hyman B Muss

  Byrl James Kennedy, MD.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(15):3297-3298.
  0

• 88.

  2005

  David G. Warr; Paul J. Hesketh; Richard J. Gralla; Hyman B. Muss; Jørn Herrstedt; Peter D. Eisenberg; Harry Raftopoulos; Steven M. Grunberg; Munir Gabriel; Anthony Rodgers; et al.

  Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

  Journal of Clinical Oncology. 2005;23(12):2822-2830.
  200

• 89.

  2005

  Hyman B Muss; Jamie Von Roenn; Lloyd Earl Damon; Lisa Marie Deangelis; Lawrence E Flaherty; Paul M Harari; Karen Kelly; Michael P Kosty; Matthew J Loscalzo; Robert Mennel; et al.

  ACCO: ASCO core curriculum outline.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(9):2049-2077.
  14

• 90.

  2005

  Hyman B. Muss; Susan Woolf; Donald Berry; Constance Cirrincione; Raymond B. Weiss; Daniel Budman; William C. Wood; I. Craig Henderson; Clifford Hudis; Eric Winer; et al.

  Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

  Journal of the American Medical Association. 2005;293(9):1073-1081.
  174

• 91.

  2005

  Gretchen G. Kimmick; Bercedis L. Peterson; Alice B. Kornblith; Jeanne Mandelblatt; Jeffrey L. Johnson; Judith Wheeler; Robin Heinze; Harvey J. Cohen; Hyman B. Muss

  Improving accrual of older persons to cancer treatment trials: A randomized trial comparing an educational intervention with standard information: CALGB 360001

  Journal of Clinical Oncology. 2005;23(10):2201-2207.
  46

• 92.

  2005

  Gretchen G. Kimmick; Bercedis L. Peterson; Alice B. Kornblith; Jeanne Mandelblatt; Jeffrey L. Johnson; Judith Wheeler; Robin Heinze; Harvey J. Cohen; Hyman B. Muss

  In reply [10]

  Journal of Clinical Oncology. 2005;23(30):7752-7753.
  0

• 93.

  2005

  Lynn G. Dressler; Donald A. Berry; Gloria Broadwater; David Cowan; Kelly Cox; Stephanie Griffin; Ashley Miller; Jessica Tse; Debra Novotny; Diane L. Persons; et al.

  Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients

  Journal of Clinical Oncology. 2005;23(19):4287-4297.
  64

• 94.

  2005

  Timothy J. Whelan; Paul E. Goss; James N. Ingle; Joseph L. Pater; Dongsheng Tu; Kathleen Pritchard; Shifang Liu; Lois E. Shepherd; Michael Palmer; Nicholas J. Robert; et al.

  Assessment of quality of life in MA. 17: A randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women

  Journal of Clinical Oncology. 2005;23(28):6931-6940.
  138

• 95.

  2005

  H.H. Hansen; D.F. Bajorin; H.B. Muss; G. Purkalne; D. Schrijvers; R. Stahel

  Erratum: Recommendations for a global core curriculum in medical oncology (Annals of Oncology (2004) vol. 15 (1603-1612))

  Annals of Oncology. 2005;16(1):177.
  0

• 96.

  2005

  Marisa F. Siebel; Hyman B. Muss

  The influence of aging on the early detection, diagnosis, and treatment of breast cancer

  Current Oncology Reports. 2005;7(1):23-30.
  6

• 97.

  2004

  Jonathan D. Eneman; Marie E. Wood; Hyman B. Muss

  Selecting adjuvant endocrine therapy for breast cancer

  ONCOLOGY. 2004;18(14):1733-1743.
  2

• 98.

  2004

  H.H. Hansen; D.F. Bajorin; H.B. Muss; G. Purkalne; D. Schrijvers; R. Stahel

  Recommendations for a global core curriculum in medical oncology

  Annals of Oncology. 2004;15(11):1603-1612.
  16

• 99.

  2004

  Susan Burdette-Radoux; Hyman B. Muss

  The Tack/Palmieri/Perez article reviewed

  ONCOLOGY. 2004;18(11):1378-1381.
  0

• 100.

  2004

  Kevin S. Hughes; Lauren A. Schnaper; Donald Berry; Constance Cirrincione; Beryl McCormick; Brenda Shank; Judith Wheeler; Lorraine A. Champion; Thomas J. Smith; Barbara L. Smith; et al.

  Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

  New England Journal of Medicine. 2004;351(10):971-977.
  392

• 101.

  2004

  Richard F. Branda; Shelly J. Naud; Elice M. Brooks; Zhuan Chen; Hyman Muss

  Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy-induced mucositis and neutropenia

  Cancer. 2004;101(5):1058-1064.
  17

• 102.

  2004

  Gretchen Kimmick; Hyman B. Muss

  Breast Cancer in Older Patients

  Seminars in Oncology. 2004;31(2):234-248.
  21

• 103.

  2004

  Hyman B. Muss; Dan L. Longo

  Introduction: Cancer in the Elderly

  Seminars in Oncology. 2004;31(2):125-127.
  7

• 104.

  2004

  Gretchen Kimmick; Mark J. Ratain; Don Berry; Susan Woolf; Larry Norton; Hyman B. Muss

  Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: A Phase II study of the Cancer and Leukemia Group B (CALGB 9041)

  Investigational New Drugs. 2004;22(1):83-89.
  3

• 105.

  2004

  Heine H. Hansen; Dean F. Bajorin; Hyman B. Muss; Gunta Purkalne; Dirk Schrijvers; Rolf Stahel

  Recommendations for a global core curriculum in medical oncology

  Journal of Clinical Oncology. 2004;22(22):4616-4625.
  15

• 106.

  2004

  Eric P. Winer; Donald A. Berry; Susan Woolf; David Duggan; Alice Kornblith; Lyndsay N. Harris; Richard A. Michaelson; Jeffrey A. Kirshner; Gini F. Fleming; Michael C. Perry; et al.

  Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and leukemia group B trial 9342

  Journal of Clinical Oncology. 2004;22(11):2061-2068.
  160

• 107.

  2003

  H.B. Muss

  Adjuvant therapy for older women breast cancer

  Breast. 2003;12(6):550-557.
  7

• 108.

  2003

  Paul E. Goss; James N. Ingle; Silvana Martino; Nicholas J. Robert; Hyman B. Muss; Martine J. Piccart; Monica Castiglione; Dongsheng Tu; Lois E. Shepherd; Kathleen I. Pritchard; et al.

  A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

  New England Journal of Medicine. 2003;349(19):1793-1802.
  1141

• 109.

  2003

  Susan Burdette-Radoux; Hyman B. Muss

  Optimizing the use of anthracyclines in the adjuvant treatment of early-stage breast cancer

  Clinical Breast Cancer. 2003;4(4):264-272.
  4

• 110.

  2003

  Hyman B. Muss

  Paris and New York: More in common than you think!

  Journal of Clinical Oncology. 2003;21(17):3189-3190.
  0

• 111.

  2003

  Chris E. Holmes; Hyman B. Muss

  Diagnosis and treatment of breast cancer in the elderly

  Ca-A Cancer Journal for Clinicians. 2003;53(4):227-244.
  67

• 112.

  2003

  M. Margaret Kemeny; Bercedis L. Peterson; Alice B. Kornblith; Hyman B. Muss; Judith Wheeler; Ellis Levine; Nancy Bartlett; Gini Fleming; Harvey J. Cohen

  Barriers to clinical trial participation by older women with breast cancer

  Journal of Clinical Oncology. 2003;21(12):2268-2275.
  165

• 113.

  2003

  Marc L. Citron; Donald A. Berry; Constance Cirrincione; Clifford Hudis; Eric P. Winer; William J. Gradishar; Nancy E. Davidson; Silvana Martino; Robert Livingston; James N. Ingle; et al.

  Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

  Journal of Clinical Oncology. 2003;21(8):1431-1439.
  798

• 114.

  2003

  I. Craig Henderson; Donald A. Berry; George D. Demetri; Constance T. Cirrincione; Lori J. Goldstein; Silvana Martino; James N. Ingle; M. Robert Cooper; Daniel F. Hayes; Katherine H. Tkaczuk; et al.

  Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer

  Journal of Clinical Oncology. 2003;21(6):976-983.
  748

• 115.

  2003

  Robert J. Motzer; Robert Amato; Mary Todd; Wen-J Poo Hwu; Roger Cohen; Jose Baselga; Hyman Muss; Michael Cooper; Richard Yu; Michelle S. Ginsberg; et al.

  Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma

  Investigational New Drugs. 2003;21(1):99-101.
  117

• 116.

  2002

  Alice B. Kornblith; Margaret Kemeny; Bercedis L. Peterson; Judith Wheeler; Jeffrey Crawford; Nancy Bartlett; Gini Fleming; Stephen Graziano; Hyman Muss; Harvey Jay Cohen

  Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials

  Cancer. 2002;95(5):989-996.
  79

• 117.

  2002

  Gretchen G. Kimmick; Brent J. Shelton; L. Douglas Case; M. Robert Cooper; Hyman B. Muss

  Long-term follow-up of a phase ii trial studying a weekly doxorubicin-based multiple drug adjuvant therapy for stage II node-positive carcinoma of the breast

  Breast Cancer Research and Treatment. 2002;72(3):233-243.
  7

• 118.

  2001

  H.B. Muss

  Older age--not a barrier to cancer treatment.

  New England Journal of Medicine. 2001;345(15):1127-1128.
  20

• 119.

  2001

  Hyman B. Muss

  Older age - Not a barrier to cancer treatment

  New England Journal of Medicine. 2001;345(15):1128-1129.
  12

• 120.

  2001

  Hyman B. Muss

  Role of adjuvant endocrine therapy in early-stage breast cancer

  Seminars in Oncology. 2001;28(4):313-321.
  16

• 121.

  2001

  H.B. Muss

  Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status.

  Journal of the National Cancer Institute. Monographs. 2001;(30):52-55.
  35

• 122.

  2001

  J. Koh; P. Burch; K. Godin; B. Beatty; M. Pinet; J.Y. Bunn; D. Tam; L. Simmons-Arnold; D. Weaver; H.B. Muss

  Cyclin D1 predicts tamoxifen benefit in women with early stage ER+ breast cancer

  Breast Cancer Research and Treatment. 2001;69(3):246.
  0

• 123.

  2001

  Gretchen G. Kimmick; Hyman B. Muss

  Systemic therapy for older women with breast cancer

  ONCOLOGY. 2001;15(3):280-291.
  15

• 124.

  2000

  Donald A Berry; Hyman B. Muss; Ann D. Thor; Lynn Dressler; Edison T. Liu; Gloria Broadwater; Dan R. Budman; I. Craig Henderson; Maurice Barcos; Daniel Hayes; et al.

  HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer

  Journal of Clinical Oncology. 2000;18(20):3471-3479.
  131

• 125.

  2000

  Prudence B. Lam; Pamela M. Vacek; Berta M. Geller; Hyman B. Muss

  The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont

  Cancer. 2000;89(2):369-375.
  66

• 126.

  2000

  Hyman B. Muss; Harvey J. Cohen; Stuart M. Lichtman

  Clinical research in the older cancer patient

  Hematology/Oncology Clinics of North America. 2000;14(1):283-291.
  20

• 127.

  2000

  Julie J. Olin; Hyman B. Muss

  New strategies for managing metastatic breast cancer

  ONCOLOGY. 2000;14(5):629-641.
  14

• 128.

  1999

  Thomas J. Smith; Nancy E. Davidson; David V. Schapira; Eva Grunfeld; Hyman B. Muss; Victor G. Vogel III; Mark R. Somerfield

  American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines

  Journal of Clinical Oncology. 1999;17(3):1080-1082.
  184

• 129.

  1999

  J. O'Shaughnessy; J. Horton; J. O'Shaughnessy; E.A. Perez; H.B. Muss

  Salvage chemotherapy for metastatic breast cancer

  Cancer Control. 1999;6(5 SUPPL.):22-27.
  2

• 130.

  1999

  Jeffrey Abrams; Joseph Aisner; Constance Cirrincione; Donald A. Berry; Hyman B. Muss; M. Robert Cooper; I. Craig Henderson; Lawrence Panasci; Jeffrey Kirshner; John Ellerton; et al.

  Dose-response trial of megestrol acetate in advanced breast cancer: Cancer and leukemia group B phase III study 8741

  Journal of Clinical Oncology. 1999;17(1):64-73.
  17

• 131.

  1999

  E.A. Perez; J. Horton; E.A. Perez; H.B. Muss

  Management of bone metastases in advanced breast cancer

  Cancer Control. 1999;6(5 SUPPL.):28-31.
  1

• 132.

  1999

  H.B. Muss; E.A. Perez; Jr. Sledge G.W.; J. O'Shaughnessy

  New hormones for advanced breast cancer

  Cancer Control. 1999;6(5 SUPPL.):12-16.
  0

• 133.

  1999

  Jr. Sledge G.W.; J. O'Shaughnessy; Jr. Sledge G.W.; E.A. Perez; H.B. Muss; J. Horton

  First-line chemotherapy for advanced breast cancer

  Cancer Control. 1999;6(5 SUPPL.):17-21.
  3

• 134.

  1999

  J. Horton; H.B. Muss; D. Slamon; E.A. Perez

  Management principles

  Cancer Control. 1999;6(5 SUPPL.):4-6.
  0

• 135.

  1998

  Ann D. Thor; Donald A. Berry; Daniel R. Budman; Hyman B. Muss; Timothy Kute; I. Craig Henderson; Maurice Barcos; Constance Cirrincione; Susan Edgerton; Craig Allred; et al.

  erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

  Journal of the National Cancer Institute. 1998;90(18):1346-1360.
  476

• 136.

  1998

  Daniel R. Budman; Donald A. Berry; Constance T. Cirrincione; I. Craig Henderson; William C. Wood; Raymond B. Weiss; Carolyn R. Ferree; Hyman B. Muss; Mark R. Green; Larry Norton; et al.

  Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer

  Journal of the National Cancer Institute. 1998;90(16):1205-1211.
  344

• 137.

  1998

  G.G. Kimmick; H.B. Muss

  Endocrine therapy in metastatic breast cancer.

  Cancer treatment and research. 1998;94:231-254.
  16

• 138.

  1997

  Daniel W. Chan; Roy A. Beveridge; Hyman Muss; Herbert A. Fritsche; Gabriel Hortobagyi; Richard Theriault; David Kiang; B.J. Kennedy; Mike Evelegh

  Use of truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease

  Journal of Clinical Oncology. 1997;15(6):2322-2328.
  71

• 139.

  1997

  Gretchen G. Kimmick; Ronald Fleming; Hyman B. Muss; Lodovico Balducci

  Cancer chemotherapy in older adults. A tolerability perspective

  Drugs and Aging. 1997;10(1):34-49.
  45

• 140.

  1997

  G. Kimmick; H.B. Muss

  Breast cancer in older women

  Clinics in Geriatric Medicine. 1997;13(2):265-282.
  11

• 141.

  1997

  Jana T. Kuss; Hyman B. Muss; Helena Hoen; L. Douglas Case

  Tamoxifen as initial endocrine therapy for metastatic breast cancer: Long term follow-up of two Piedmont Oncology Association (POA) trials

  Breast Cancer Research and Treatment. 1997;42(3):265-274.
  17

• 142.

  1997

  Bronagh Murphy; Hyman B. Muss

  Hormonal therapy of breast cancer: State of the art

  ONCOLOGY. 1997;11(5 SUPPL. 4):7-13.
  2

• 143.

  1996

  Electra D. Paskett; Hyman B. Muss; L. Douglas Case; M. Robert Cooper

  Participation in clinical treatment trials: Factors affecting participation for women with breast cancer

  Journal of Women's Health. 1996;5(6):585-592.
  6

• 144.

  1996

  Ronald A. Fleming; Robert L. Capizzi; Hyman B. Muss; Stephen Smith; Daniel J. Fernandes; Howard Homesley; Brian W. Loggie; L. Douglas Case; Reba Morris; Gregory B. Russell; et al.

  Phase I study of N-(Phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer

  Clinical Cancer Research. 1996;2(7):1107-1114.
  8

• 145.

  1996

  John L. Currie; John A. Blessing; Hyman B. Muss; Jeffrey Fowler; Michael Berman; Thomas W. Burke

  Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: A Gynecologic Oncology Group study

  Gynecologic Oncology. 1996;61(1):27-30.
  33

• 146.

  1996

  James N. Atkins; Hyman B. Muss; L. Douglas Case; Frederick Richards II; Thomas Grote; James McFarland

  Leucovorin and high-dose fluorouracil in metastatic prostate cancer: A phase II trial of the Piedmont Oncology Association

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1996;19(1):23-25.
  13

• 147.

  1996

  Hyman B. Muss

  Postoperative follow-up after early-stage breast cancer

  Breast Journal. 1996;2(4):281-285.
  1

• 148.

  1996

  Emily Robinson; Gretchen G. Kimmick; Hyman B. Muss

  Tamoxifen in postmenopausal women: A safety perspective

  Drugs and Aging. 1996;8(5):329-337.
  35

• 149.

  1996

  H.B. Muss

  Breast cancer in older women

  Seminars in Oncology. 1996;23(1 SUPPL. 2):82-88.
  25

• 150.

  1996

  Jeffrey F. Patton; Bayard L. Powell; Douglas R. White; Gregory B. Russell; Robin T. Inabinet; Hyman B. Muss

  Combination cisplatin and carboplatin in advanced squamous cell carcinoma of the head and neck

  Cancer Investigation. 1996;14(2):98-102.
  4

• 151.

  1995

  Joseph Aisner; Constance Cirrincione; Marjorie Perloff; Michael Perry; Daniel Budman; Jeffrey Abrams; Lawrence Panasci; Hyman Muss; Marc Citron; James Holland; et al.

  Combination chemotherapy for metastatic or recurrent carcinoma of the breast - A randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and leukemia group B study 8281

  Journal of Clinical Oncology. 1995;13(6):1443-1452.
  29

• 152.

  1995

  H.B. Muss

  Breast cancer in the elderly: Treatment of metastatic disease

  Cancer Control. 1995;2(2 SUPPL.):39-42.
  1

• 153.

  1995

  H.B. Muss; M. Brady; R. Park

  Age and gynecologic cancer: The Gynecologic Oncology Group Experience

  Cancer Control. 1995;2(2 SUPPL.):17-18.
  0

• 154.

  1995

  G. Kimmick; H.B. Muss

  Current status of endocrine therapy for metastatic breast cancer

  ONCOLOGY. 1995;9(9):877-886+889-890.
  18

• 155.

  1995

  H.D. Homesley; H.B. Muss; R.F. Ozols

  Role of chemotherapy dose intensification in the treatment of advanced ovarian cancer. Commentaries

  ONCOLOGY. 1995;9(10):922+924+926.
  0

• 156.

  1995

  R.M. Mayberry; R.J. Coates; H.A. Hill; L.A. Click; V.W. Chen; D.F. Austin; C.K. Redmond; C.M. Fenoglio-Preiser; C.P. Hunter; M.A. Haynes; et al.

  Determinants of black/white differences in colon cancer survival

  Journal of the National Cancer Institute. 1995;87(22):1686-1693.
  137

• 157.

  1995

  G. Kimmick; H.B. Muss

  Breast cancer in older women

  Breast Journal. 1995;1(5):300-307.
  0

• 158.

  1995

  K.Y. Look; H.B. Muss; J.A. Blessing; M. Morris

  A phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent epithelial ovarian carcinoma: A Gynecologic Oncology Group Study

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1995;18(1):19-22.
  30

• 159.

  1995

  H.B. Muss

  Chemotherapy of breast cancer in the older patient

  Seminars in Oncology. 1995;22(1 SUPPL. 1):14-16.
  17

• 160.

  1995

  R.P. McQuellon; H.B. Muss; S.L. Hoffman; G. Russell; B. Craven; S.B. Yellen

  Patient preferences for treatment of metastatic breast cancer: A study of women with early-stage breast cancer

  Journal of Clinical Oncology. 1995;13(4):858-868.
  116

• 161.

  1995

  T.E. Kute; Y. Quadri; H. Muss; N. Zbieranski; C. Cirrincione; D.A. Berry; M. Barcos; A.P. Thor; E. Liu; F. Koerner; et al.

  Flow cytometry in node-positive breast cancer: Cancer and leukemia group B protocol 8869

  Communications in Clinical Cytometry. 1995;22(4):297-306.
  27

• 162.

  1994

  J. William Eley; Holly A. Hill; Vivien W. Chen; Donald F. Austin; Margaret N. Wesley; Hyman B. Muss; Raymond S. Greenberg; Ralph J. Coates; Pelayo Correa; et al.

  Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study

  Journal of the American Medical Association. 1994;272(12):947-954.
  395

• 163.

  1994

  Hyman B. Muss; L. Douglas Case; James N. Atkins; James D. Bearden III; M. Robert Cooper; Julia M. Cruz; Don V. Jackson Jr.; Mark A. O'Rourke; Michael D. Pavy; Bayard L. Powell; et al.

  Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: A Piedmont Oncology Association study

  Journal of Clinical Oncology. 1994;12(8):1630-1638.
  48

• 164.

  1994

  H.B. Muss

  The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women

  Cancer. 1994;74(7 SUPPL.):2165-2171.
  22

• 165.

  1994

  C.D. Atkins; H.B. Muss; L.D. Case

  Tamoxifen versus medroxyprogesterone acetate for metastatic breast cancer [2]

  Journal of Clinical Oncology. 1994;12(11):2515-2516.
  0

• 166.

  1994

  J.J. Perry; H.B. Muss

  Management of disseminated disease in the patient with bladder cancer

  Urologic Clinics of North America. 1994;21(4):661-672.
  7

• 167.

  1994

  H.B. Muss

  Chemotherapy of metastatic endometrial cancer

  Seminars in Oncology. 1994;21(1):107-113.
  38

• 168.

  1994

  G.W. Thomas; H.B. Muss; D.V. Jackson; J. McCulloch; W. Ramseur; J. McFarland; H. Hoen; M. Pavy; R. Heath

  Vincristine with high-dose etoposide in advanced breast cancer: A phase II trial of the piedmont oncology association

  Cancer Chemotherapy and Pharmacology. 1994;35(2):165-168.
  0

• 169.

  1994

  Vivien W. Chen; Pelayo Correa; Robert J. Kurman; Xiao-Cheng Wu; J. William Eley; Donald Austin; Hyman Muss; Carrie P. Hunter; Carol Redmond; et al.

  Histological characteristics of breast carcinoma in blacks and whites

  Cancer Epidemiology Biomarkers and Prevention. 1994;3(2):127-135.
  136

• 170.

  1994

  H.B. Muss; A.D. Thor; D.A. Berry; T. Kute; E.T. Liu; F. Koerner; C.T. Cirrincione; D.R. Budman; W.C. Wood; et al.

  c-erbB-2 expression and response to adjuvant therapy in women with node- positive early breast cancer

  New England Journal of Medicine. 1994;330(18):1260-1266.
  788

• 171.

  1994

  H.-J. Muller; C.H. Gletter; U. Gundert-Remy; D. Melnychuk; L.C. Panasci; C.M.L. Coppin; J.H. Goldie; C. Sauter; J. Garey; S. Lehrer; et al.

  Adjuvant therapy for breast cancer [1]

  New England Journal of Medicine. 1994;331(11):741-746.
  0

• 172.

  1993

  C.P. Hunter; C.K. Redmond; V.W. Chen; D.F. Austin; R.S. Greenberg; P. Correa; H.B. Muss; M.R. Forman; M.N. Wesley; R.S. Blacklow; et al.

  Breast cancer: Factors associated with stage at diagnosis in Black and White women

  Journal of the National Cancer Institute. 1993;85(14):1129-1137.
  148

• 173.

  1993

  H.B. Muss; J.A. Blessing; B. DuBeshter

  Echinomycin in recurrent and metastatic endometrial carcinoma: A Phase II trial of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1993;16(6):492-493.
  8

• 174.

  1992

  Julia M. Cruz; L.Douglas Case; Howell B. Dalton; William L. Ramseur; Frederick Richards II; Don V. Jackson; Hyman B. Muss; Patricia J. Zekan; Richard A. Brodkin; R.C. Brown; et al.

  Menogaril in the treatment of relapsed multiple myeloma - A phase II trial of the Cancer Center of Wake Forest University

  Investigational New Drugs. 1992;10(1):35-37.
  2

• 175.

  1992

  H.B. Muss; C.P. Hunter; M. Wesley; P. Correa; V.W. Chen; R.S. Greenberg; J.W. Eley; D.F. Austin; R. Kurman; et al.

  Treatment plans for black and white women with Stage II node-positive breast cancer: The National Cancer Institute Black/White Cancer Survival Study Experience

  Cancer. 1992;70(10):2460-2467.
  70

• 176.

  1992

  D.J. Schifeling; D.V. Jackson; P.J. Zekan; H.B. Muss

  Fluoxymesterone as third line endocrine therapy for advanced breast cancer: A Phase II trial of the Piedmont Oncology Association

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1992;15(3):233-235.
  2

• 177.

  1992

  K. Christman; H.B. Muss; L.D. Case; V. Stanley

  Chemotherapy of metastatic breast cancer in the elderly: The Piedmont Oncology Association experience

  Journal of the American Medical Association. 1992;268(1):57-62.
  146

• 178.

  1992

  H.B. Muss

  Metastatic breast cancer and chemotherapy

  Biomedicine and Pharmacotherapy. 1992;46(8):379.
  0

• 179.

  1992

  H.B. Muss

  Endocrine therapy for advanced breast cancer: A review

  Breast Cancer Research and Treatment. 1992;21(1):15-26.
  98

• 180.

  1992

  R.J. Coates; D.D. Bransfield; M. Wesley; B. Hankey; J.W. Eley; R.S. Greenberg; D. Flanders; C.P. Hunter; B.K. Edwards; M. Forman; et al.

  Differences between Black and White women with breast cancer in time from symptom recognition to medical consultation

  Journal of the National Cancer Institute. 1992;84(12):938-950.
  86

• 181.

  1992

  H.B. Muss; J.M. Cruz

  High-dose progestin therapy for metastatic breast cancer

  Annals of Oncology. 1992;3(SUPPL. 3):15-20.
  4

• 182.

  1992

  H.B. Muss; J.A. Blessing; P. Hanjani; J.H. Malfetano; G.M. Kemp; K. Webster

  Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix: A phase II trial of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1992;15(4):363-364.
  2

• 183.

  1992

  M. Davis; S. Williford; H.B. Muss; D.R. White; M.R. Cooper; D.V. Jackson; R. Barrett

  A phase I-II study of recombinant intrapleural alpha interferon in malignant pleural effusions

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1992;15(4):328-330.
  11

• 184.

  1992

  H.B. Muss; L. Balducci

  Breast cancer in the elderly: The current status of systemic adjuvant therapy

  Journal of Experimental and Clinical Cancer Research. 1992;11(3):169-175.
  0

• 185.

  1992

  J.M. Cruz; H.B. Muss; G. Russell

  High-Dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer

  Oncology. 1992;49(SUPPL. 2):8-11.
  1

• 186.

  1992

  K.Y. Look; J.A. Blessing; H.B. Muss; K. DeGeest

  5-Fluorouracil and low-dose leucovorin in the treatment of recurrent epithelial ovarian carcinoma: A Phase II trial of the gynecologic oncology group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1992;15(6):494-496.
  16

• 187.

  1992

  K.Y. Look; J.A. Blessing; H.B. Muss; E.E. Partridge; J.H. Malfetano

  5-Fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix: A phase II trial of the gynecologic oncology group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1992;15(6):497-499.
  6

• 188.

  1992

  H.B. Muss; J.A. Blessing; G.L. Eddy; R. McGehee

  Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG)

  Investigational New Drugs. 1992;10(1):25-26.
  7

• 189.

  1991

  G. Kimmick; H.B. Muss; L.D. Case; V. Stanley

  A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer: The Piedmont Oncology Association experience

  Cancer. 1991;67(11):2850-2854.
  28

• 190.

  1991

  H.B. Muss; G.S. Tell; L.D. Case; P. Robertson; B.M. Atwell

  Perceptions of follow-up care in women with breast cancer

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1991;14(1):55-59.
  32

• 191.

  1991

  H.B. Muss; L.D. Case; F. Richards II; D.R. White; M.R. Cooper; J.M. Cruz; B.L. Powell; C.L. Spurr; R.L. Capizzi

  Interrupted versus continuous chemotherapy in patients with metastatic breast cancer

  New England Journal of Medicine. 1991;325(19):1342-1348.
  106

• 192.

  1991

  L. Loomer; J.K. Brockschmidt; H.B. Muss; G. Saylor

  Postoperative follow-up of patients with early breast cancer. Patterns of care among clinical oncologists and a review of the literature

  Cancer. 1991;67(1):55-60.
  32

• 193.

  1991

  M.L. O'Connor; D.T. Rice; D.H. Buss; H.B. Muss

  Immunoglobulin D benign monoclonal gammopathy: A case report

  Cancer. 1991;68(3):611-616.
  10

• 194.

  1991

  H.B. Muss; B.N. Bundy; L. Adcock

  Teniposide (VM-26) in patients with advanced endometrial carcinoma: A phase II trial of the gynecologic oncology group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1991;14(1):36-37.
  8

• 195.

  1991

  J.N. Atkins; H.B. Muss; D. Case; J. Brockschmidt; F.M. Schnell; M. O'Rourke; T.H. Grote; J.H. West; S. Anthony; et al.

  High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer: A phase II trial of the Piedmont Oncology Association

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1991;14(6):526-529.
  12

• 196.

  1991

  H.B. Muss; M.R. Cooper; J.K. Brockschmidt; C. Ferree; F. Richards II; D.R. White; D.V. Jackson; C.L. Spurr

  A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial

  Breast Cancer Research and Treatment. 1991;19(2):77-84.
  31

• 197.

  1991

  H.B. Muss

  The use of interferon in renal cell carcinoma

  European Journal of Cancer. 1991;27(SUPPL. 4):S84-S87.
  6

• 198.

  1990

  Gregory W. Evans; Mark A. Espeland; L.Douglas Case; Hyman B. Muss

  Resampling methods for repeated measures in clinical trials

  Controlled Clinical Trials. 1990;11(4):261.
  0

• 199.

  1990

  Q.Scott Ringenberg; Kathleen J. Propert; Hyman B. Muss; Raymond B. Weiss; Richard L. Schilsky; Caron Modeas; Michael C. Perry; Larry Norton; Mark Green

  Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected cases - A Cancer and Leukemia Group B report

  Investigational New Drugs. 1990;8(2):221-226.
  1

• 200.

  1990

  D.V. Jackson Jr.; J.M. Cruz; D.R. White; H.B. Muss; A.R. Chauvenet

  Combination high-dose etoposide and vincristine infusion

  Investigational New Drugs. 1990;8(SUPPL. 1):S59-S64.
  0

• 201.

  1990

  J.M. Cruz; H.B. Muss; J.K. Brockschmidt; G.W. Evans

  Weight changes in women with metastatic breast cancer treated with megestrol acetate: A comparison of standard versus high-dose therapy

  Seminars in Oncology. 1990;17(6 SUPPL. 9):63-67.
  26

• 202.

  1990

  D.V. Jackson Jr.; J.B. Craig; C.L. Spurr; D.R. White; H.B. Muss; J.M. Cruz; F. Richards; B.L. Powell

  Vincristine infusion with CHOP-CCNU in diffuse large-cell lymphoma

  Cancer Investigation. 1990;8(1):7-12.
  1

• 203.

  1990

  H.B. Muss; J.A. Blessing; J. Malfetano

  Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the gynecologic oncology group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(3):191-193.
  4

• 204.

  1990

  R.J. Zagoria; H.B. Muss; N.T. Wolfman; R.H. Choplin; N. Karstaedt; M.C. Garovich

  Computed tomography versus chest radiography: Impact on management of patients with lymphoma

  Cancer Investigation. 1990;8(3-4):357-364.
  0

• 205.

  1990

  H.B. Muss; B.N. Bundy; L. Adcock; J. Beecham

  Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(1):32-34.
  28

• 206.

  1990

  H.B. Muss; D. Van Echo; A.H. Korzun; I.G. Henderson; T. Campbell; N.J. Vogelzang; M.A. Rice; W. Wood

  Esorubicin (4'-deoxydoxorubicin, NSC 267469) in advanced breast cancer. A phase II study of the CALGB

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(3):233-237.
  0

• 207.

  1990

  T.E. Kute; H.B. Muss; M.R. Cooper; L.D. Case; D. Buss; V. Stanley; B. Gregory; J. Galleshaw; K. Booher

  The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients

  Cancer. 1990;66(8):1810-1816.
  19

• 208.

  1990

  H.B. Muss; J.A. Blessing; V.V. Baker; D.R. Barnhill; M.D. Adelson

  Echinomycin (NSC 526417) in advanced ovarian cancer. A Phase II trial of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(4):299-301.
  8

• 209.

  1990

  H.B. Muss; L.D. Case; R.L. Capizzi; M.R. Cooper; J. Cruz; D. Jackson; F. Richards II; B.L. Powell; C.L. Spurr; et al.

  High- versus standard-dose megestrol acetate in women with advanced breast cancer: A phase III trial of the Piedmont Oncology Association

  Journal of Clinical Oncology. 1990;8(11):1797-1805.
  32

• 210.

  1990

  H.B. Muss; N. Spell; D. Scudiery; R.L. Capizzi; M.R. Cooper; J. Cruz; D.V. Jackson; F. Richards II; C.L. Spurr; et al.

  A phase II trial of peg-L-asparaginase in the treatment of non-Hodgkins lymphoma

  Investigational New Drugs. 1990;8(1):125-130.
  23

• 211.

  1990

  H.B. Muss; J.A. Blessing; K.D. Hatch; J.T. Soper; K.D. Webster; G.M. Kemp

  Methotrexate in advanced endometrial carcinoma. A Phase II trial of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(1):61-63.
  8

• 212.

  1990

  H.B. Muss; B.N. Bundy; F.T. Given; F.B. Stehman

  Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the gynecologie oncology group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(2):117-118.
  1

• 213.

  1990

  D.R. White; B.L. Powell; J.B. Craig; R.K. Stuart; F.M. Schnell; G.A. Goldklang; J.N. Atkins; D.V. Jackson; F. Richards II; H.B. Muss; et al.

  A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study

  Cancer. 1990;65(8):1700-1703.
  1

• 214.

  1989

  W.L. McGuire; P.A. Johnson; H.B. Muss; C.K. Osborne

  Megestrol acetate in breast cancer - A panel discussion

  Breast Cancer Research and Treatment. 1989;14(1):33-38.
  1

• 215.

  1989

  D.V. Jackson Jr.; J.M. Cruz; P.J. Zekan; M.E. Caponera; C.L. Spurr; D.R. White; F. Richards II; H.B. Muss

  Phase I study of vincristine and escalating doses of etoposide

  Investigational New Drugs. 1989;7(2-3):203-207.
  0

• 216.

  1989

  H.D. Homesley; C.W. Scarantino; H.B. Muss; C.E. Welander

  Concurrent chemotherapy and single high-dose plus whole abdominopelvic radiation for persistent ovarian carcinoma

  Gynecologic Oncology. 1989;34(2):170-174.
  4

• 217.

  1989

  H.B. Muss; T.E. Kute; L.D. Case; L.R. Smith; C. Booher; R. Long; L. Kammire; B. Gregory; J.K. Brockschmidt

  The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

  Cancer. 1989;64(9):1894-1900.
  37

• 218.

  1989

  D.V. Jackson; B.L. Powell; J.M. Cruz; C.L. Spurr; H.B. Muss

  Infusion of etoposide and vincristine in non-Hodgkin's lymphoma

  Selective Cancer Therapeutics. 1989;5(3):129-136.
  0

• 219.

  1989

  B.L. Powell; R.L. Capizzi; H.B. Muss; J.D. Bearden; E.S. Lyerly; D.L. Rosenbaum; T.M. Morgan; F. Richards; D.V. Jackson; D.R. White; et al.

  Low-dose ara-C therapy for acute myelogenous leukemia in elderly patients

  Leukemia. 1989;3(1):23-28.
  18

• 220.

  1989

  J.M. Sterchi; F. Richards; D.R. White; H.B. Muss; M.R. Cooper; D.V. Jackson; C.L. Spurr; R.L. Capizzi; J. Cruz; et al.

  Chemoinfusion of the hepatic artery for metastases to the liver

  Surgery Gynecology and Obstetrics. 1989;168(4):291- 295.
  1

• 221.

  1989

  W.J. Smith; H.B. Muss; R.L. Capizzi; D.R. White; F. Richards II; D.V. Jackson; B.L. Powell; P.J. Zekan

  Mitoxantrone and high-dose ara-C in refractory malignancies: A phase I trial

  Medical and Pediatric Oncology. 1989;17(2):159-163.
  1

• 222.

  1989

  H.B. Muss; B.N. Bundy; W.A. Christopherson

  Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group Study

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1989;12(2):142-144.
  12

• 223.

  1989

  G.R. Ainge; R.H. Choplin; R.E. Bechtold; H.B. Muss; L.D. Case; T.E. Kute

  Relationship between mammographic features and hormone receptor content in patients with breast cancer

  Southern Medical Journal. 1989;82(12):1506-1511.
  2

• 224.

  1988

  D.V. Jackson Jr.; L.D. Case; P.J. Zekan; B.L. Powell; R.D. Caldwell; J.D. Bearden; E.C. Nelson; H.B. Muss; M.R. Cooper; et al.

  Improvement of long-term survival in extensive small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988;6(7):1161-1169.
  21

• 225.

  1988

  H.B. Muss; H.B. Wells; E.H. Paschold; W.R. Black; M.R. Cooper; R.L. Capizzi; R. Christian; J.M. Cruz; D.V. Jackson; et al.

  Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988;6(7):1098-1106.
  37

• 226.

  1988

  H.B. Muss

  Interferon therapy of metastatic renal cell cancer

  Seminars in Surgical Oncology. 1988;4(3):199-203.
  11

• 227.

  1988

  H.B. Muss

  The role of biological response modifiers in metastatic renal cell carcinoma

  Seminars in Oncology. 1988;15(5 SUPPL. 5):30-34.
  16

• 228.

  1988

  J.M. Bennett; H.B. Muss; J.H. Doroshow; S. Wolff; E.T. Krementz; K. Cartwright; G. Dukart; A. Reisman; I. Schoch

  A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

  Journal of Clinical Oncology. 1988;6(10):1611-1620.
  74

• 229.

  1988

  H.B. Muss; M.J.C. McNamara; R.A. Connelly

  Follow-up after stage II breast cancer: A comparative study of relapsed versus nonrelapsed patients

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1988;11(4):451-455.
  10

• 230.

  1988

  B.L. Powell; J.B. Craig; H.B. Muss; P.J. Zekan; M.R. Cooper; F.M. Schnell; J.W. Hampton; D.R. White; L.R. Smith; R.L. Capizzi

  Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association study

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1988;11(5):550-552.
  2

• 231.

  1988

  L.F. Diehl; A. Banks; W. Carter; M.A. Klein; H.B. Muss; R.B. Weiss

  Fatal esorubicin-induced cardiomyopathy: Report of a case and review of the literature

  Cancer Chemotherapy and Pharmacology. 1988;21(4):347-350.
  0

• 232.

  1988

  P.A. Johnson; H. Muss; P. Bonomi; J. Von Roenn; J. Wolter; E. Paschold; W. Black; M. Cooper

  Megestrol acetate as primary hormonal therapy for advanced breast cancer

  Seminars in Oncology. 1988;15(2 SUPPL. 1):34-37.
  1

• 233.

  1988

  D.V. Jackson; H.B. Wells; J.N. Atkins; P.J. Zekan; D.R. White; F. Richards II; J.M. Cruz; H.B. Muss

  Amelioration of vincristine neurotoxicity by glutamic acid

  American Journal of Medicine. 1988;84(6):1016-1022.
  50

• 234.

  1988

  B.L. Powell; R.L. Capizzi; D.V. Jackson; F. Richards; H.B. Muss; E.S. Lyerly; D.L. Rosenbaum; R.A. Connelly; D.H. Buss; J.D. Bearden; et al.

  Low dose ara-C for patients with myelodysplastic syndromes

  Leukemia. 1988;2(3):153-156.
  12

• 235.

  1987

  H.B. Muss

  Adjuvant irradiation following mastectomy: where are we?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987;5(10):1500-1501.
  2

• 236.

  1987

  Hyman B. Muss

  Interferon therapy for renal cell carcinoma

  Seminars in Oncology. 1987;14(2 SUPPL. 2):36-42.
  51

• 237.

  1987

  Hyman B. Muss; Brian N. Bundy; Howard D. Homesley; George Wilbanks

  Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (A phase II trial of the gynecologic oncology group)

  Investigational New Drugs. 1987;5(2):199-202.
  2

• 238.

  1987

  Bayard L. Powell; Hyman B. Muss; Robert L. Capizzi; Mary E. Caponera; Douglas R. White; Patricia J. Zekan; James N. Atkins; Don V. Jackson Jr.; Frederick Richards II; John B. Craig; et al.

  Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies

  Cancer Chemotherapy and Pharmacology. 1987;19(3):250-252.
  0

• 239.

  1987

  J.M. Sterchi; H.B. Muss; N. Weidner

  Cellular blue nevus simulating metastatic melanoma: Report of an unusually large lesion associated with nevus-cell aggregates in regional lymph nodes

  Journal of Surgical Oncology. 1987;36(1):71-75.
  21

• 240.

  1987

  H.B. Muss; B.N. Bundy; R. Yazigi; E. Yordan

  Teniposide in squamous cell carcinoma of the cervix: A phase II trial of the Gynecologic Oncology Group

  Cancer Treatment Reports. 1987;71(9):873-874.
  1

• 241.

  1987

  S.L. Curry; H.B. Muss; J.A. Blessing; J. Arseneau

  Hematologic monitoring in patients with cancer. A study of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1987;10(2):163-166.
  1

• 242.

  1987

  J.B. Craig; D.V. Jackson; F.R. Richards II.; H.B. Muss; D.R. White; M.R. Cooper; J.J. Stuart; C.L. Spurr

  Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexate

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1987;10(1):44-46.
  0

• 243.

  1987

  H.B. Muss; J.J. Costanzi; R. Leavitt; R.D. Williams; R.A. Kempf; R. Pollard; H. Ozer; P.J. Zekan; S.M. Grunberg; M.S. Mitchell

  Recombinant alfa interferon in renal cell carcinoma: A randomized trial of two routes of administration

  Journal of Clinical Oncology. 1987;5(2):286-291.
  67

• 244.

  1987

  H.B. Muss; B.N. Bundy; P.J. DiSaia; C.E. Ehrlich

  Mitoxantrone for carcinoma of the endometrium: A phase II trial of the Gynecologic Oncology Group

  Cancer Treatment Reports. 1987;71(2):217-218.
  6

• 245.

  1987

  H.B. Muss; L.R. Smith; M.R. Cooper

  Tamoxifen rechallenge: Response to tamoxifen following relapse after adjuvant chemohormonal therapy for breast cancer

  Journal of Clinical Oncology. 1987;5(10):1556-1558.
  14

• 246.

  1987

  Hyman B. Muss; Vernon W. Jobson; Howard D. Homesley; Charles Welander; Carolyn Ferree

  Neoadjuvant therapy for advanced squamous cell carcinoma of the cervix: Cisplatin followed by radiation therapy-A pilot study of the gynecologic oncology group

  Gynecologic Oncology. 1987;26(1):35-40.
  7

• 247.

  1987

  D.V. Jackson; C.L. Spurr; M.E. Caponera; D.R. White; H.B. Muss; M.D. Pavy; G.P. Sartiano; P.J. Zekan; E.A. Hire

  Vinblastine infusion in non-Hodgkin's lymphomas: Lack of total cross-resistance with vincristine

  Cancer Investigation. 1987;5(6):535-539.
  1

• 248.

  1986

  Hyman B. Muss; Mary Caponera; Patricia J. Zekan; Don V. Jackson Jr.; John J. Stuart; Frederick Richards; M.Robert Cooper; Elizabeth A. Levin; Steven D. Reich; Robert L. Capizzi

  Recombinant gamma interferon in advanced breast cancer: A phase II trial

  Investigational New Drugs. 1986;4(4):377-381.
  2

• 249.

  1986

  D.S. Ettinger; J. Allegra; J.R. Bertino; P. Bonomi; H. Browder; P. Byrne; J. Carpenter; R. Catalano; R. Creech; B. Dana; et al.

  Megestrol acetate v tamoxifen in advanced breast cancer: Correlation of hormone receptors and response

  Seminars in Oncology. 1986;13(4 SUPPL. 4):9-14.
  14

• 250.

  1986

  Bayard L. Powell; Hyman B. Muss; J.Michael Sterchi

  Focal leukemia around a raaf catheter as the initial site of relapse

  The American Journal of Medicine. 1986;81(5):945.
  0

• 251.

  1986

  Bayard L. Powell; John B. Craig; Hyman B. Muss

  Secondary penile malignancies

  Diseases of the Colon & Rectum. 1986;29(8):543.
  0

• 252.

  1986

  Don V. Jackson Jr.; Ellen K. Pope; Renee A. McMahan; M. Robert Cooper; James N. Atkins; Richard D. Callahan; Eugene H. Paschold; Ruby A. Grimm; Judith O. Hopkins; Hyman B. Muss; et al.

  Clinical trial of pyridoxine to reduce vincristine neurotoxicity

  Journal of Neuro-Oncology. 1986;4(1):37-41.
  22

• 253.

  1986

  F. Richards II.; L.D. Case; D.R. White; H.B. Muss; C.L. Spurr; D.V. Jackson; M.R. Cooper; P. Zekan; J. Cruz; J.J. Stuart

  Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the piedmont oncology association

  Journal of Clinical Oncology. 1986;4(4):565-570.
  15

• 254.

  1986

  H.D. Homesley; C.E. Welander; H.B. Muss; F. Richards

  Dosage range study of morphine sulfate controlled-release

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1986;9(5):449-453.
  4

• 255.

  1986

  B.L. Powell; P.J. Zekan; H.B. Muss; F. Richards II; E.S. Lyerly; R.L. Capizzi

  Ara-C syndrome during low-dose continuous infusion therapy

  Medical and Pediatric Oncology. 1986;14(6):310-312.
  4

• 256.

  1986

  H. Muss; B.N. Bundy; P.J. DiSaia; L.B. Twiggs

  Teniposide in epithelial ovarian carcinoma: A phase II trial of the Gynecologic Oncology Group

  Cancer Treatment Reports. 1986;70(10):1231-1232.
  2

• 257.

  1985

  Joseph C. Allegra; J. Bertino; P. Bonomi; P. Byrne; John Carpenter; R. Catalano; R. Creech; B. Dana; H. Durivage; L. Einhorn; et al.

  Metastatic breast cancer: Preliminary results with oral hormonal therapy

  Seminars in Oncology. 1985;12(4 SUPPL. 6):61-64.
  6

• 258.

  1985

  Hyman B. Muss; Robert L. Capizzi; James N. Atkins; Bayard L. Powell; M.Robert Cooper; Dawn Ferree; Renee A. McMahan; Vernon Jobson; Johnny Craig; Howard D. Homesley; et al.

  Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies

  Seminars in Oncology. 1985;12(2 SUPPL. 3):166-170.
  0

• 259.

  1985

  John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charles Vogel; Edward Krementz; Franco Muggia; James Doroshow; David Plotkin; et al.

  A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer

  Investigational New Drugs. 1985;3(2):179-185.
  4

• 260.

  1985

  Timothy E. Kute; Hyman B. Muss; Marbry Hopkins; Richard Marshall; Douglas Case; Leslie Kammire

  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer

  Breast Cancer Research and Treatment. 1985;6(2):113-121.
  5

• 261.

  1985

  Bayard L. Powell; Don V. Jackson Jr.; Charles W. Scarantino; Ellen Pope; Robert Choplin; Johnny B. Craig; James N. Atkins; M.Robert Cooper; Judith O. Hopkins; Renee McMahan; et al.

  Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis

  International Journal of Radiation Oncology, Biology, Physics. 1985;11(3):457-462.
  0

• 262.

  1985

  H.B. Muss; B. Bundy; P.J. DiSaia; H.D. Homesley; W.C. Fowler Jr.; W. Creasman; E. Yordan

  Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide. (A phase III trial of the gynecologic oncology group)

  Cancer. 1985;55(8):1648-1653.
  78

• 263.

  1985

  H.B. Muss; H.D. Homesley; S.A. Rudnick

  A phase I trial of recombinant leukocyte a₂ interferon in patients with advanced malignancy

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1985;8(2):97-107.
  0

• 264.

  1985

  B.L. Powell; J.B. Craig; H.B. Muss

  Secondary malignancies of the penis and epididymis: A case report and review of the literature

  Journal of Clinical Oncology. 1985;3(1):110-116.
  45

• 265.

  1985

  J.N. Atkins; H.B. Muss; R.L. Capizzi; M.R. Cooper; J. Craig; J.M. Cruz; D.V. Jackson Jr.; B. Powell; F. Richards II; C.L. Spurr

  Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancy

  Cancer Treatment Reports. 1985;69(7-8):897-899.
  0

• 266.

  1985

  H.B. Muss; E.H. Paschold; W.R. Black; M.R. Cooper; R.L. Capizzi; R. Christian; J.M. Cruz; D.V. Jackson; J.J. Stuart; F. Richards II

  Megestrol acetate v tamoxifen in advanced breast cancer: A phase III trial of the piedmont oncology association (POA)

  Seminars in Oncology. 1985;12(1 SUPPL. 1):55-61.
  7

• 267.

  1985

  H.B. Muss; T.R. Kute; L. Danese

  Flow cytometry (FC) and disease recurrence in node negative (N-) breast cancer

  Proceedings of the American Association for Cancer Research. 1985;VOL. 26:No. 110.
  0

• 268.

  1985

  J.M. Sterchi; H.B. Wells; L.D. Case; C.L. Spurr; D.R. White; F. Richards; H.B. Muss; D.V. Jackson; J.J. Stuart; M.R. Cooper

  A randomized trial of adjuvant chemotherapy and immunotherapy in stage I and stage II cutaneous melanoma. An interim report

  Cancer. 1985;55(4):707-712.
  13

• 269.

  1985

  J.N. Atkins; H.B. Muss

  Schistocytes in erythroleukemia

  American Journal of the Medical Sciences. 1985;289(3):110-113.
  4

• 270.

  1985

  H.B. Muss; C. Welander; M. Caponera; K. Reavis; J.M. Cruz; M.R. Cooper; D.V. Jackson Jr.; F. Richards II; J.J. Stuart; C.L. Spurr

  Interferon and doxorubicin in renal cell carcinoma

  Cancer Treatment Reports. 1985;69(6):721-722.
  4

• 271.

  1985

  K.M. Harrison; H.B. Muss; M.R. Ball; M. McWhorter; D. Case

  Spinal cord compression in breast cancer

  Cancer. 1985;55(12):2839-2844.
  15

• 272.

  1985

  J.W. Hartz; K.R. Geisinger; M. Scharyj; H.B. Muss

  Granulomatous pneumocystosis presenting as a solitary pulmonary nodule

  Archives of Pathology and Laboratory Medicine. 1985;109(5):466-469.
  9

• 273.

  1985

  E.S. Christian; J.B. Craig; H.B. Muss; R.D. Michaelson

  Human T-cell leukemia lymphoma syndrome

  American Family Physician. 1985;32(1):155-160.
  0

• 274.

  1985

  H.B. Muss; D. Case; M.R. Cooper; F. Richards II; C.L. Spurr; M.I. Resnick; P. Zekan; E.C. Nelson; J.B. Puckett; E. Pope

  Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate: A phase II trial of the Piedmont Oncology Association

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1985;8(5):396-400.
  0

• 275.

  1985

  H.B. Muss; G.P. Sutton; B. Bundy; K.D. Hatch

  Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the gynecologic oncology group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1985;8(4):312-315.
  6

• 276.

  1984

  Don V. Jackson Jr.; Ellen K. Pope; L.Douglas Case; H.Bradley Wells; Douglas R. White; M.Robert Cooper; Ronald D. Caldwell; William R. Black; Hyman B. Muss; Julia M. Cruz; et al.

  Improved tolerance of vincristine by glutamic acid - A preliminary report

  Journal of Neuro-Oncology. 1984;2(3):219-222.
  2

• 277.

  1984

  Don V. Jackson Jr.; V.Sagar Sethi; Tony R. Long; Hyman B. Muss; Charles L. Spurr

  Pharmacokinetics of vindesine bolus and infusion

  Cancer Chemotherapy and Pharmacology. 1984;13(2):114-119.
  2

• 278.

  1984

  Johnny Craig; Bayard Powell; Hyman B. Muss; Ernest Kawamoto; Robert Breyer

  Second primary bronchogenic carcinomas after small cell carcinoma. Report of two cases and review of the literature

  The American Journal of Medicine. 1984;76(6):1013-1020.
  7

• 279.

  1984

  D.R. White; H.B. Muss; R. Michielutte; M.R. Cooper; D.V. Jackson; F. Richards 2nd.; J.J. Stuart; C.L. Spurr

  Informed consent: patient information forms in chemotherapy trials.

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1984;7(2):183-190.
  23

• 280.

  1984

  Julia M. Cruz; Don V. Jackson Jr.; Hyman B. Muss; Charles L. Spurr; Robert L. Capizzi

  Detection of brain metastasis at diagnosis of small cell carcinoma of the lung

  Journal of Neuro-Oncology. 1984;2(1):67-71.
  3

• 281.

  1984

  J.B. Craig; B.L. Powell; H.B. Muss

  Thymoma

  American Family Physician. 1984;29(3):229-234.
  1

• 282.

  1984

  R.L. Capizzi; M. Poole; M.R. Cooper; F. Richards II; J.J. Stuart; D.V. Jackson Jr.; D.R. White; C.L. Spurr; J.O. Hopkins; H.B. Muss

  Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase

  Blood. 1984;63(3):694-700.
  44

• 283.

  1984

  H.B. Muss; M. Slavik; B. Bundy

  A phase study II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A gynecologic oncology group study

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1984;7(3):257-260.
  3

• 284.

  1984

  H.B. Muss; D.V. Jackson Jr.; F. Richards II

  Bone marrow evaluation in small cell lung cancer

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1984;7(1):59-63.
  2

• 285.

  1984

  H. Muss; R. Asbury; B. Bundy; C.E. Ehrlich; J. Graham

  Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1984;7(6):737-739.
  7

• 286.

  1984

  H.B. Muss; B. Bundy; P.J. DiSaia; F.B. Stehman; J. Beecham

  PALA (NSC-224131) in advanced carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1984;7(6):741-744.
  1

• 287.

  1984

  B.L. Powell; J.B. Craig; H.B. Muss

  Thyroid cancer

  American Family Physician. 1984;30(5):185-192.
  0

• 288.

  1984

  J. Hopkins; F. Richards II.; D. Case; E. Pope; D.V. Jackson Jr.; J.J. Stuart; H.B. Muss; D.R. White; M.R. Cooper; C.L. Spurr

  A phase II study of dibromodulcitol (DBD) in stage IV melanoma

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1984;7(5):555-556.
  1

• 289.

  1984

  H.B. Muss; R.A. Kempf; S. Martino; S.A. Rudnick; J. Greiner; M.R. Cooper; D. Decker; S.M. Grunberg; D.V. Jackson; F. Richards II

  A phase II study of recombinant α interferon in patients with recurrent or metastatic breast cancer

  Journal of Clinical Oncology. 1984;2(9):1012-1016.
  4

• 290.

  1984

  P.J. Zekan; H.B. Muss; R.L. Capizzi; M.R. Cooper; R.W. Harding; J.O. Hopkins; D.V. Jackson; W.L. Ramseur; F. Richards II; C.L. Spurr

  High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase II study of the piedmont oncology association (POA)

  Cancer. 1984;54(11):2338-2343.
  3

• 291.

  1984

  V.W. Jobson; H.B. Muss; J.T. Thigpen; H.D. Homesley; B. Bundy

  Chemotherapy of advanced squamous carcinoma of the cervix: A phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1984;7(4):341-345.
  5

• 292.

  1984

  D.V. Jackson Jr.; E.H. Paschold; C.L. Spurr; H.B. Muss; F. Richards II; M.R. Cooper; D.R. White; J.J. Stuart; J.O. Hopkins; R. Rich Jr.

  Treatment of advanced non-Hodkgin's lymphoma with vincristine infusion

  Cancer. 1984;53(12):2601-2606.
  12

• 293.

  1983

  Don V. Jackson Jr.; Hyman B. Muss; Fred Richards II; Douglas R. White; Charles L. Spurr; M.Robert Cooper; Richard M. Christian; Thomas F. Trahey; L.Douglas Case; H.Bradley Wells

  CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma

  Cancer Chemotherapy and Pharmacology. 1983;11(3):191-195.
  0

• 294.

  1983

  Sharon K. Shipp; Hyman B. Muss; Mary Alice Westrick; M.Robert Cooper; V. Don Jackson; Frederick C. Richards; Douglas R. White; John J. Stuart; Richard M. Christian; William Ramseur; et al.

  Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF) - A clinical trial of the piedmont oncology association (POA)

  Cancer Chemotherapy and Pharmacology. 1983;11(2):130-133.
  0

• 295.

  1983

  M. Slavik; H. Muss; J.A. Blessing

  Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix

  Cancer Treatment Reports. 1983;67(2):195-196.
  1

• 296.

  1983

  S.L. Bower; R.H. Choplin; H.B. Muss

  Multiple primary bronchogenic carcinomas of the lungs

  American Journal of Roentgenology. 1983;140(2):253-258.
  15

• 297.

  1983

  D.V. Jackson Jr.; H.B. Wells; D.R. White; H.B. Muss; F. Richards II; M.R. Cooper; J.J. Stuart; E.K. Pope; C.L. Spurr

  Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1983;6(3):327-330.
  4

• 298.

  1983

  J.O. Hopkins; D.V. Jackson Jr.; D.R. White; H.B. Muss; F. Richards II; M.R. Cooper; J.J. Stuart; C.L. Sparr; H.B. Wells

  Vincristine by continuous infusion in refractory breast cancer: A phase II study

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1983;6(5):529-532.
  0

• 299.

  1983

  J.P. Gusdon Jr.; H.D. Homesley; V.W. Jobson; H.B. Muss

  Treatment of advanced ovarian malignancy with chemoimmunotherapy using autologous tumor and Corynebacterium parvum

  Obstetrics and Gynecology. 1983;62(6):728-735.
  2

• 300.

  1982

  B.A. Wall; M.E. Weinblatt; J.T. Darnall; H. Muss

  Candida tropicalis arthritis and bursitis

  Journal of the American Medical Association. 1982;248(9):1098-1099.
  6

• 301.

  1982

  B.R. Paschal; H.B. Muss; F. Richards II.; M.R. Cooper; D.R. White; D.V. Jackson; J.J. Stuart; C.L. Spurr

  Nonseminomatous germ cell cancer of the testis. Reducing treatment-related morbidity in patients with disseminated disease

  Cancer. 1982;50(9):1742-1745.
  0

• 302.

  1982

  B.R. Paschal; H.B. Muss; F. Richards II.; M.R. Cooper; D.R. White; D.V. Jackson; J.J. Stuart; C.L. Spurr

  Nonseminomatous germ-cell cancer of the testis. Reducing treatment-related morbidity in patients with disseminated disease

  Cancer. 1982;50(4):668-671.
  0

• 303.

  1982

  H.B. Muss; F. Richards II; D.V. Jackson; M.R. Cooper; D.R. White; J.J. Stuart; W. Ramseur; R.M. Christian; H.B. Wells; E. Pope; et al.

  Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer. A randomized trial of the Piedmont Oncology Association

  Cancer. 1982;50(11):2269-2274.
  4

• 304.

  1982

  P.J. Zekan; H.B. Muss; E. Pope

  High-dose cyclophosphamide and fluorouracil (CF) versus vincristine (V), doxorubicin (A), and cyclophosphamide (C) as first line therapy for advanced breast carcinoma

  Breast Cancer Research and Treatment. 1982;2(3):295.
  0

• 305.

  1982

  P.S. Pegram; H.B. Muss; C.E. McCall

  A comparative study of moxalactam (M) vs ticarcillin and tobramycin (TT) in febrile neutropenic cancer patients

  Proceedings of the American Society of Clinical Oncology. 1982;Vol. 1:C-255.
  0

• 306.

  1982

  M. Slavik; H. Muss; J.A. Blessing; G. Delgado

  Phase II clinical study of Yoshi 864 in epithelial ovarian carcinoma: A Gynecologic Oncology Group study

  Cancer Treatment Reports. 1982;66(9):1775-1777.
  2

• 307.

  1982

  R. Cooper; H. Muss; C. Ferree

  Long-term evaluation of a randomized adjuvant study of chemotherapy (CT) with and without radiation therapy (RT) for stage II breast cancer

  Breast Cancer Research and Treatment. 1982;2(3):294.
  0

• 308.

  1981

  E.H. Paschold; H.B. Muss

  Current concepts in the management of breast cancer.

  American Family Physician. 1981;24(3):119-126.
  0

• 309.

  1981

  C.H. Pippitt Jr.; H.B. Muss; H.D. Homesley; V.W. Jobson

  Cisplatin-associated cortical blindness

  Gynecologic Oncology. 1981;12(2 I):253-255.
  17

• 310.

  1981

  R.A. Grimm; H.B. Muss; R.B. Patterson

  Reactivation of Hand-Schuller-Christian disease six and thirteen years after discontinuation of systemic therapy

  Medical and Pediatric Oncology. 1981;9(1):17-21.
  2

• 311.

  1981

  V.S. Sethi; D.V. Jackson Jr.; D.R. White; F. Richards II; J.J. Stuart; H.B. Muss; M.R. Cooper; C.L. Spurr

  Pharmacokinetics of vincristine sulfate in adult cancer patients

  Cancer Research. 1981;41(9 I):3551-3555.
  22

• 312.

  1981

  H.B. Muss; F. Richards II; D.V. Jackson

  A randomized trial of vincristine (V), adriamycin (A) and cyclophosphamide (C) versus low dose cyclophosphamide, methotrexate (M), and fluorouracil (F)

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:584.
  0

• 313.

  1981

  M.R. Cooper; E.R. Heise; F. Richards II; H.B. Muss; D.R. White; L. Rhyne; V. Howard; C.L. Spurr

  A prospective study of histocompatible leukocyte and platelet transfusions during induction chemotherapy of adult acute nonlymphocytic leukemia

  Medical and Pediatric Oncology. 1981;9(3):225-234.
  0

• 314.

  1981

  H.B. Muss; F. Richards; M.R. Cooper; D.R. White; D.V. Jackson; J.J. Stuart; V. Howard; A. Shore; A.L. Rhyne; C.L. Spurr

  Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus calmette-guerin (MER) in advanced breast cancer: A randomized trial by the Piedmont Oncology Association

  Cancer. 1981;47(9):2295-2301.
  3

• 315.

  1981

  D. Payne; H.B. Muss; H.D. Homesley; V.W. Jobson; F.G. Baird

  Autoimmune hemolytic anemia and ovarian dermoid cysts: Case report and review of the literature

  Cancer. 1981;48(3):721-724.
  18

• 316.

  1981

  F. Richarda II; D.V. Jackson; H.B. Muss

  CMAP (CCNU, Methotrexate, Adriamycin, with Cis-Platinum) in advanced non-small cell lung cancer

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-189.
  0

• 317.

  1981

  T.E. Kute; H.B. Muss; D. Anderson; K. Crumb; B. Miller; D. Burns; L.A. Dube

  Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer

  Cancer Research. 1981;41(9 I):3524-3529.
  4

• 318.

  1981

  H.B. Muss; V. Howard; F. Richards II; D.R. White; D.V. Jackson; M.R. Cooper; J.J. Stuart; M.I. Resnick; R. Brodkin; C.L. Spurr

  Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial

  Cancer. 1981;47(8):1949-1953.
  12

• 319.

  1981

  V.W. Jobson; H.B. Muss; J.T. Thigpen; H.D. Homesley

  Chemotherapy of advanced carcinoma of the cervix with cyclophosphamide and cisplatin. A pilot study of the gynecologic oncology group

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-557.
  0

• 320.

  1981

  J.P. Gusdon Jr.; H.D. Homesley; H.B. Muss; E.R. Heise; G.A. Herbst; F. Richards II; C.L. Spurr; J.V. Lovelace; P.J. Di Saia

  Chemotherapy of advanced ovarian epithelial carcinoma with melphalan and levamisole: A pilot study of the gynecologic oncology group

  American Journal of Obstetrics and Gynecology. 1981;141(1):65-70.
  1

• 321.

  1981

  R. Cooper; H. Muss; C. Ferree

  Follow-up evaluation of a randomized adjuvant study of chemotherapy (CT) with and without irradiation therapy (RT) for stage II breast cancer

  Breast Cancer Research and Treatment. 1981;1(2):No. 71.
  0

• 322.

  1981

  M.R. Cooper; A.L. Rhyne; H.B. Muss; C. Ferree; F. Richards II; D.R. White; J.J. Stuart; D.V. Jackson; V. Howard; A. Shore; et al.

  A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer

  Cancer. 1981;47(12):2833-2839.
  12

• 323.

  1981

  S.K. Shipp; M.A. Westrick; H.B. Muss

  Vincristine (V), doxorubicin (D), and mitomycin (MI) in patients with metastatic breast cancer failing prior cyclophosphamide (C), methotrexate (M), and fluorouracil (F)

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-191.
  0

• 324.

  1981

  B.R. Paschal; H.B. Muss; F. Richards II

  'Low-dose' cis-platinum (CPPD) in advanced non-seminomatous testicular cancer (NSTC)

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-190.
  0

• 325.

  1981

  E.H. Paschold; M.L. Slatkoff; H.B. Muss

  Hormonal therapy of advanced breast cancer: Efficacy and toxicity of diethylstilbestrol (DES) vs. tamoxifen (TAM)

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-186.
  1

• 326.

  1980

  R.A. Grimm; H.B. Muss; D.R. White; F. Richards IInd; M.R. Cooper; J.J. Stuart; D.V. Jackson; P.L. Barnes; C.L. Spurr

  Actinomycin D in the treatment of advanced breast cancer

  Cancer Chemotherapy and Pharmacology. 1980;4(3):195-197.
  1

• 327.

  1980

  D.R. White; F. Richards II; H.B. Muss; M.R. Cooper; C.L. Spurr

  Therapy of advanced colorectal carcinoma with 5-fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate

  Cancer. 1980;45(4):662-665.
  0

• 328.

  1980

  F. Richards II; M.R. Cooper; D.R. White; H.B. Muss; D.V. Jackson; J.J. Stuart; C.L. Spurr

  Advanced epidermoid lung cancer. Prolonged survival after chemotherapy

  Cancer. 1980;46(1):34-37.
  0

• 329.

  1979

  D.R. White; M.R. Cooper; H.B. Muss; F. Richards 2nd.; C.L. Spurr

  Complications of cytotoxic antineoplastic chemotherapy.

  North Carolina medical journal. 1979;40(2):73-78.
  1

• 330.

  1979

  H.B. Muss; F. Richards II; P.L. Barnes; V.V. Willard; R.J. Cowan

  Radionuclide scanning in patients with advanced malignant melanoma

  Clinical Nuclear Medicine. 1979;4(12):516-518.
  5

• 331.

  1979

  F. Richards II; D.R. White; H.B. Muss; D.V. Jackson; J.J. Stuart; M.R. Cooper; L. Rhyne; C.L. Spurr

  Combination chemotherapy of advanced non-oat cell carcinoma of the lung

  Cancer. 1979;44(5):1576-1581.
  0

• 332.

  1979

  D.R. White; J.J. Maloney III; H.B. Muss; R.P. Vance; P. Barnes; V. Howard; L. Rhyne; R.J. Cowan

  Serum alkaline phosphatase determination. Value in the staging of advanced breast cancer

  Journal of the American Medical Association. 1979;242(11):1147-1149.
  4

• 333.

  1979

  F. Richards II; H.B. Muss; M.R. Cooper; D.R. White; J.J. Stuart; V. Howard; P. Barnes; L. Rhyne; C.L. Spurr

  Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum. A prospective randomized study

  Cancer. 1979;43(1):91-96.
  7

• 334.

  1979

  H.B. Muss; D.R. White; R. Michielutte; F. Richards IInd; M.R. Cooper; S. Williams; J.J. Stuart; C.L. Spurr

  Written informed consent in patients with breast cancer

  Cancer. 1979;43(4):1549-1556.
  36

• 335.

  1979

  F. Richards II; D.R. White; H.B. Muss

  Adjuvant chemotherapy with vincristine, methyl - CCNU methotrexate versus 5-fluorouracil following surgery in colonic cancer

  Proceedings of the American Association for Cancer Research. 1979;Vol. 20:No. C-315.
  0

• 336.

  1979

  D.V. Jackson Jr.; F. Richards II; H.B. Muss

  Immunotherapy of small cell carcinoma of the lung (SCC): A randomized study

  Proceedings of the American Association for Cancer Research. 1979;Vol. 20:No. C-314.
  0

• 337.

  1979

  M.R. Cooper; H. Muss; M. Raben

  A randomized adjuvant study of L-phenylalanine mustard (L-PAM) and cyclophosphamide, methotrexate and fluorouracil (CMF) with and without radiation therapy (RT) for stage II breast cancer

  Proceedings of the American Association for Cancer Research. 1979;Vol. 20:No.C-127.
  0

• 338.

  1979

  H.B. Muss; M.R. Cooper; F. Richards II

  Chemo- versus chemoimmunotherapy in advanced breast cancer

  Proceedings of the American Association for Cancer Research. 1979;Vol. 20:No. C-267.
  0

• 339.

  1978

  M.R. Cooper; H.B. Muss; F. Richards; J.J. Stuart; D.R. White; C.L. Spurr

  The treatment of the lymphomas.

  North Carolina medical journal. 1978;39(12):707-711.
  0

• 340.

  1978

  H.B. Muss; D.R. White; F. Richards 2nd.; M.R. Cooper; J.J. Stuart; C.L. Spurr

  Current concepts: management of breast cancer.

  North Carolina medical journal. 1978;39(10):593-596.
  0

• 341.

  1978

  F. Richards 2nd.; H.B. Muss; D.R. White; C. Ferree; J. Stuart; M.R. Cooper; C.L. Spurr

  Management of lung cancer.

  North Carolina medical journal. 1978;39(9):535-540.
  0

• 342.

  1978

  H.B. Muss; D.R. White

  Iron deficiency anemia in adults.

  American Family Physician. 1978;17(2):174-185.
  0

• 343.

  1978

  J.D. Davis; H.B. Muss; R.A. Turner

  Cytotoxic agents in the treatment of rheumatoid arthritis

  Southern Medical Journal. 1978;71(1):58-64.
  2

• 344.

  1978

  H.B. Muss; D.R. White; F. Richards II

  Chemo- versus chemoimmunotherapy in advanced breast cancer

  Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No.C-123.
  0

• 345.

  1978

  F. Richards II.; D.R. White; H.B. Muss

  Chemo- and chemoimmunotherapy in patients with advanced colorectal carcinoma

  Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No. C - 358.
  0

• 346.

  1978

  R. Cooper; H. Muss; F. Richards II

  A randomized clinical trial of L-phenylalanine mustard (L-PAM) and cyclophosphamide, methotrexate, and fluorouracil (CMF) with and without radiation therapy (R.T.) for adjuvant therapy of breast cancer

  Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No.C-124.
  0

• 347.

  1978

  H.D. Homesley; R.M. Cooper; H.B. Muss

  Vincristine, cyclophosphamide, and adriamycin in advanced ovarian cancer

  Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No. C-435.
  0

• 348.

  1978

  P.C. Galle; H.B. Muss; K.M. McGrath; J.J. Stuart; H.D. Homesley

  Thrombocytopenia in two patients treated with low-dose heparin

  Obstetrics and Gynecology. 1978;52(SUPP.1):9s-11s.
  4

• 349.

  1978

  H.B. Muss; D.R. White; F. Richards II; M.R. Copper; J.J. Stuart; C.L. Spurr

  Vinblastine and 6-thioguanine in the treatment of advanced breast cancer

  Cancer Treatment Reports. 1978;62(8):1233-1235.
  1

• 350.

  1978

  L.R. DeChatelet; R.A. Migler; P.S. Shirley; H.B. Muss; P. Szejda; D.A. Bass

  Comparison of intracellular bactericidal activities of human neutrophils and eosinophils

  Blood. 1978;52(3):609-617.
  10

• 351.

  1978

  H.B. Muss; D.R. White; F. Richards II; M.R. Cooper; J.J. Stuart; D.V. Jackson; L. Rhyne; C.L. Spurr

  Adriamycin versus methotrexate in five drug combination chemotherapy for advanced breast cancer. A randomized trial

  Cancer. 1978;42(5):2141-2148.
  23

• 352.

  1977

  H.B. Muss; D.R. White; M.R. Cooper

  Randomized study of two five drug regimens in advanced breast cancer

  Proceedings of the American Association for Cancer Research. 1977;Vol. 18:No. C-22.
  0

• 353.

  1977

  H.B. Muss; D.R. White; M.R. Cooper; F. Richards IInd; C.L. Spurr

  Combination chemotherapy in advanced breast cancer. A randomized trial comparing a three- vs. a five-drug program

  Archives of Internal Medicine. 1977;137(12):1711-1714.
  4

• 354.

  1977

  L.R. DeChatelet; P.S. Shirley; L.C. McPhail; C.C. Huntley; H.B. Muss; D.A. Bass

  Oxidative metabolism of the human eosinophil

  Blood. 1977;50(3):525-535.
  42

• 355.

  1977

  D.V. Jackson Jr.; F. Richards II; M.R. Cooper; C. Ferree; H.B. Muss; D.R. White; C.L. Spurr

  Prophylactic cranial irradiation in small cell carcinoma of the lung: A randomized study

  Journal of the American Medical Association. 1977;237(25):2730-2733.
  32

• 356.

  1977

  M. Haid; H.L. Homesley; D.R. White; M.R. Cooper; F. Richards IIIrd; H.B. Muss; C.L. Spurr

  Adriamycin methotrexate combination chemotherapy of advanced carcinoma of the cervix. A second look

  Obstetrics and Gynecology. 1977;50(1):103-105.
  0

• 357.

  1977

  F. Richards II; H.B. Muss; D.R. White; M.R. Cooper; C.L. Spurr

  CCNU, bleomycin, and methylprednisolone with or without adriamycin in renal cell carcinoma: a randomized trial

  Cancer Treatment Reports. 1977;61(8):1591-1593.
  0

• 358.

  1976

  H.B. Muss; D.R. White; F. Richards; M.R. Cooper; C.L. Spurr

  Adriamycin and CCNU in the treatment of advanced breast cancer

  Cancer Treatment Reports. 1976;60(11):1687-1689.
  0

• 359.

  1976

  F. Richards II; M.R. Cooper; H.B. Muss; D.R. White; C.L. Spurr

  Methyl CCNU, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma

  Cancer. 1976;38(3):1077-1082.
  0

• 360.

  1976

  H.B. Muss; D.R. White; R.J. Cowan

  Brain scanning in patients with recurrent breast cancer

  Cancer. 1976;38(4):1574-1576.
  1

• 361.

  1976

  H.B. Muss; M.R. Cooper; F. Richards; C.L. Spurr

  A randomized study of two five drug regimens in advanced breast cancer

  Proceedings of the American Association for Cancer Research. 1976;Vol.17:No.C-139.
  0

• 362.

  1975

  H.B. Muss; J.J. Lokich; E. Frei III

  5 Fluorouracil with cytosine arabinoside in metastatic gastrointestinal cancer

  Clinical Pharmacology and Therapeutics. 1975;18(2):234-237.
  1

• 363.

  1973

  H.B. Muss; W.C. Moloney

  Chloroma and other myeloblastic tumors

  Blood. 1973;42(5):721-728.
  125